Reply to J.-E. Bibault et al, B. Tombal, and C. Cattrini et al

J Clin Oncol. 2018 Aug 1;36(22):2351-2352. doi: 10.1200/JCO.2018.78.2144. Epub 2018 Jun 1.

Authors

Piet Ost¹, Dries Reynders¹, Karel Decaestecker¹, Valérie Fonteyne¹, Nicolaas Lumen¹, Bieke Lambert¹, Louke Delrue¹, Gert De Meerleer¹

Affiliation

¹ Piet Ost and Dries Reynders, Ghent University, Ghent, Belgium; Karel Decaestecker, Ghent University Hospital, Ghent, Belgium; Valérie Fonteyne, Ghent University, Ghent, Belgium; Nicolaas Lumen, Ghent University Hospital, Ghent, Belgium; Bieke Lambert, Ghent University and AZ Maria-Middelares Ghent, Ghent, Belgium; Louke Delrue, Ghent University Hospital, Ghent, Belgium; and Gert De Meerleer, Ghent University, Ghent, Belgium.

PMID: 29856691
DOI: 10.1200/JCO.2018.78.2144

No abstract available

Publication types

Letter
Research Support, Non-U.S. Gov't
Comment

MeSH terms

Humans
Male
Neoplasm Recurrence, Local*
Prospective Studies
Prostatic Neoplasms*